181 related articles for article (PubMed ID: 15661624)
1. Human brain imaging and substance abuse.
Lingford-Hughes A
Curr Opin Pharmacol; 2005 Feb; 5(1):42-6. PubMed ID: 15661624
[TBL] [Abstract][Full Text] [Related]
2. Positron emission tomography and single-photon emission computed tomography in substance abuse research.
Volkow ND; Fowler JS; Wang GJ
Semin Nucl Med; 2003 Apr; 33(2):114-28. PubMed ID: 12756644
[TBL] [Abstract][Full Text] [Related]
3. Addiction and imaging of the living human brain.
Gatley SJ; Volkow ND
Drug Alcohol Depend; 1998; 51(1-2):97-108. PubMed ID: 9716933
[No Abstract] [Full Text] [Related]
4. PET imaging studies in drug abuse.
Fowler JS; Volkow ND
J Toxicol Clin Toxicol; 1998; 36(3):163-74. PubMed ID: 9656971
[TBL] [Abstract][Full Text] [Related]
5. What have positron emission tomography and 'Zippy' told us about the neuropharmacology of drug addiction?
Cumming P; Caprioli D; Dalley JW
Br J Pharmacol; 2011 Aug; 163(8):1586-604. PubMed ID: 20846139
[TBL] [Abstract][Full Text] [Related]
6. Imaging neurotransmitter release by drugs of abuse.
Martinez D; Narendran R
Curr Top Behav Neurosci; 2010; 3():219-45. PubMed ID: 21161755
[TBL] [Abstract][Full Text] [Related]
7. Addiction.
Lingford-Hughes AR; Davies SJ; McIver S; Williams TM; Daglish MR; Nutt DJ
Br Med Bull; 2003; 65():209-22. PubMed ID: 12697627
[TBL] [Abstract][Full Text] [Related]
8. The addicted human brain: insights from imaging studies.
Volkow ND; Fowler JS; Wang GJ
J Clin Invest; 2003 May; 111(10):1444-51. PubMed ID: 12750391
[No Abstract] [Full Text] [Related]
9. Introduction to the special issue on neuroimaging in neuropharmacology.
Lu H; Jenkins BG; Stein EA
Neuropharmacology; 2014 Sep; 84():63-4. PubMed ID: 24859606
[No Abstract] [Full Text] [Related]
10. Imaging the neurochemistry of alcohol and substance abuse.
Martinez D; Kim JH; Krystal J; Abi-Dargham A
Neuroimaging Clin N Am; 2007 Nov; 17(4):539-55, x. PubMed ID: 17983969
[TBL] [Abstract][Full Text] [Related]
11. Structural and functional neuroimaging studies of the suicidal brain.
Desmyter S; van Heeringen C; Audenaert K
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):796-808. PubMed ID: 21216267
[TBL] [Abstract][Full Text] [Related]
12. PET-based neuropharmacology: state of the art.
Lucignani G; Moresco RM; Fazio F
Cerebrovasc Brain Metab Rev; 1989; 1(4):271-87. PubMed ID: 2701655
[TBL] [Abstract][Full Text] [Related]
13. The application of neuroimaging techniques to drug development.
Tamminga CA; Conley RR
J Clin Psychiatry; 1997; 58 Suppl 10():3-6. PubMed ID: 9265909
[TBL] [Abstract][Full Text] [Related]
14. Sustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users.
de Win MM; Jager G; Booij J; Reneman L; Schilt T; Lavini C; Olabarriaga SD; den Heeten GJ; van den Brink W
Brain; 2008 Nov; 131(Pt 11):2936-45. PubMed ID: 18842607
[TBL] [Abstract][Full Text] [Related]
15. Insights from recent positron emission tomographic studies of drug abuse and dependence.
Chang L; Haning W
Curr Opin Psychiatry; 2006 May; 19(3):246-52. PubMed ID: 16612209
[TBL] [Abstract][Full Text] [Related]
16. Is there still a place for SPET in the era of PET brain imaging?
Fotopoulos AD; Alexiou GA
Hell J Nucl Med; 2012; 15(2):89-91. PubMed ID: 22741144
[TBL] [Abstract][Full Text] [Related]
17. The application of functional magnetic resonance imaging to neuropharmacology.
Shah YB; Marsden CA
Curr Opin Pharmacol; 2004 Oct; 4(5):517-21. PubMed ID: 15351358
[TBL] [Abstract][Full Text] [Related]
18. [Multimodal imaging with PET, fMRI and genetic research].
Wrase J; Reimold M; Beck A; Heinz A
Fortschr Neurol Psychiatr; 2008 May; 76(5):278-85. PubMed ID: 18438753
[TBL] [Abstract][Full Text] [Related]
19. Food addiction: A common neurobiological mechanism with drug abuse.
Lindgren E; Gray K; Miller G; Tyler R; Wiers CE; Volkow ND; Wang GJ
Front Biosci (Landmark Ed); 2018 Jan; 23(5):811-836. PubMed ID: 28930574
[TBL] [Abstract][Full Text] [Related]
20. Altered prefrontal dopaminergic function in chronic recreational ketamine users.
Narendran R; Frankle WG; Keefe R; Gil R; Martinez D; Slifstein M; Kegeles LS; Talbot PS; Huang Y; Hwang DR; Khenissi L; Cooper TB; Laruelle M; Abi-Dargham A
Am J Psychiatry; 2005 Dec; 162(12):2352-9. PubMed ID: 16330601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
